
PROTACs: Targeting breakdown of specific proteins to treat diseases
Felicites Rapon explores the advantages of PROTACs over small molecule inhibitors in addressing cancer treatment and drug resistance.
Felicites Rapon explores the advantages of PROTACs over small molecule inhibitors in addressing cancer treatment and drug resistance.
Angelina Shcherbakowa delves into the enigma of Guam’s lytico-bodig disease, attempting to trace its potential origins.
Climate change has more negative outcomes than we think, argues Natalie Stevenson, explaining how it affects human health.
Megan Stoker reviews the current medical understanding of the enigmatic condition ME/CFS, commonly known as chronic fatigue syndrome.
Sophie Berdugo discusses how, much like the self-isolation we have become accustomed to during the COVID-19 pandemic, ants also adopt self-isolation techniques to stop the spread of fungal infections.
Figuring out the composition of the bacteria in the gut, mouth, and on the skin is very fashionable at the moment, with papers regularly linking the microbiome to an unexpected disease. However, I can’t help but wonder if microbiotics isn’t the magic wand we were hoping for. Will it stand the test of time? Studying…